Treat Complex Generics More Like NDAs In GDUFA III, Teva Says

As GDUFA III Virtual Public Meeting Kicks Off

 
• By Sue Sutter
  
Silhouette of diving board at sunset
FDA AND INDUSTRY WANT TO USE THE SUCCESSES OF GDUFA II AS A SPRINGBOARD TO A NEW GENERIC DRUG USER FEE AGREEMENT. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products